Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technical considerations in labeling of blood elements.

W C Eckelman

    Seminars in Nuclear Medicine
    |January 1, 1975
    PubMed
    Summary

    Labeling blood components like red blood cells and platelets faces technical challenges, impacting their in vivo behavior. While chromium-51 (51Cr) labeling is established, isotopes with better properties are needed for improved radiolabeled blood cell studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The past, present, and the promise of the future of nuclear medicine and biology.

    Nuclear medicine and biology·2017
    Same author

    Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.

    Molecular imaging and biology·2011
    Same author

    Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

    Molecular psychiatry·2010
    Same author

    A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

    Journal of medicinal chemistry·2008
    Same author

    Imaging of muscarinic receptors in the central nervous system.

    Current pharmaceutical design·2006
    Same author

    Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?

    European journal of nuclear medicine and molecular imaging·2005

    Area of Science:

    • Nuclear medicine
    • Hematology
    • Biomedical imaging

    Background:

    • Radiolabeling of blood components is crucial for studying their in vivo fate.
    • Current labeling techniques present technical difficulties and questions regarding cell viability.
    • There is a need for improved radiolabeling methods using isotopes with superior physical properties.

    Purpose of the Study:

    • To discuss the technical challenges in radiolabeling albumin, erythrocytes, leukocytes, and platelets.
    • To evaluate the impact of procedural variations on the in vivo behavior of radiolabeled blood elements.
    • To highlight the limitations of current labeling isotopes and the need for advancements.

    Main Methods:

    • Review of existing radiolabeling procedures for albumin, red blood cells, white blood cells, and platelets.
    • Discussion of the use of various radioisotopes, including technetium-99m (99mTc), chromium-51 (51Cr), and gallium-67 (67Ga).
    • Analysis of the clinical validation and in vivo viability of radiolabeled blood components.

    Main Results:

    • Albumin labeling with 99mTc lacks clinical proof.
    • Erythrocyte labeling with 51Cr is defined, but 99mTc-labeled red blood cells are not routine.
    • White blood cell and platelet labeling with 51Cr is established, but in vivo viability is uncertain.
    • Labeling techniques with 67Ga and 99mTc are under development.

    Conclusions:

    • Blood elements labeled with 51Cr are the best-defined currently.
    • Significant work is required to develop reliable radiolabeling methods using isotopes with better physical characteristics.
    • Advancements in radiolabeling techniques are essential for accurate in vivo fate studies of blood components.

    Related Experiment Videos